Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Fewer needles, same safety? new study tests smarter prostate cancer detection

NCT ID NCT07516223

First seen Apr 12, 2026 · Last updated May 23, 2026 · Updated 3 times

Summary

This study looks at whether men with a very high PSA level and a suspicious MRI can safely skip the extra 12 needle samples usually taken during a prostate biopsy. The standard approach uses 15-17 samples, but the extra ones can cause pain, bleeding, and infection. Researchers will compare results from 850 men to see if the fewer, targeted samples alone catch all dangerous cancers. If successful, this could make biopsies less painful and safer for high-risk patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSA PROGRESSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.